<DOC>
	<DOC>NCT01329887</DOC>
	<brief_summary>This study is an evaluation of the effect of ketanserine on sublingual microcirculation in intensive care patients with severe sepsis.</brief_summary>
	<brief_title>The Effect of Ketanserin on the Microcirculation in Sepsis</brief_title>
	<detailed_description>This is a pilot study, including 10 ICU patients with severe sepsis with MFI &lt; 2,5 after fulfillment of a strict resuscitation protocol. At the start of the study, a baseline SDF measurement is made, when MFI &lt; 2,5 inclusion in the study is permitted and intravenous ketanserin administration is started and subsequently increased, guided by the effect on sublingual MFI, until a safe maximum dosage is reached. Safety margins for hypotension are defined in the study protocol.</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock, Septic</mesh_term>
	<mesh_term>Ketanserin</mesh_term>
	<criteria>severe sepsis and MFI &lt; 2,5 after resuscitation age &lt; 18 year old pregnant participation other trials prolonged Qt interval</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>microcirculation</keyword>
	<keyword>SDF</keyword>
	<keyword>ketanserin</keyword>
	<keyword>severe sepsis</keyword>
</DOC>